JC virus Reactivation During Prolonged Natalizumab Monotherapy for Multiple Sclerosis

OBJECTIVE: To determine the prevalence of JC virus (JCV) reactivation and JCV-specific cellular immune response during prolonged natalizumab treatment for multiple sclerosis (MS). METHODS: We enrolled 43 JCV-seropositive MS patients, including 32 on natalizumab monotherapy>18 months, 6 on interfe...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Ann Neurol
Prif Awduron: Chalkias, Spyridon, Dang, Xin, Bord, Evelyn, Stein, Marion C., Kinkel, R. Philip, Sloane, Jacob A., Donnelly, Maureen, Ionete, Carolina, Houtchens, Maria K., Buckle, Guy J., Batson, Stephanie, Koralnik, Igor J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2014
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4425205/
https://ncbi.nlm.nih.gov/pubmed/24687904
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ana.24148
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg